Fractionated whole body γ-irradiation aggravates arthritic severity via boosting NLRP3 and RANKL expression in adjuvant-induced arthritis model: the mitigative potential of ebselen.

Abstract

Rheumatoid arthritis (RA) is an autoimmune chronic inflammatory disease associated with oxidative stress that causes excruciating pain, discomfort, and joint destruction. Ebselen (EB), a synthesized versatile organo-selenium compound, protects cells from reactive oxygen species (ROS)-induced injury by mimicking glutathione peroxidase (GPx) action. This study aimed to investigate the antioxidant and anti-inflammatory effects of EB in an arthritic irradiated model. This goal was achieved by subjecting adjuvant-induced arthritis (AIA) rats to fractionated whole body γ-irradiation (2 Gy/fraction once per week for 3 consecutive weeks, for a total dose of 6 Gy) and treating them with EB (20 mg/kg/day, p.o) or methotrexate (MTX; 0.05 mg/kg; twice/week, i.p) as a reference anti-RA drug. The arthritic clinical signs, oxidative stress and antioxidant biomarkers, inflammatory response, expression of NOD-like receptor protein-3 (NLRP-3) inflammasome, receptor activator of nuclear factor κB ligand (RANKL), nuclear factor-κB (NF-κB), apoptotic indicators (caspase 1 and caspase 3), cartilage integrity marker (collagen-II), and histopathological examination of ankle joints were assessed. EB notably improved the severity of arthritic clinical signs, alleviated joint histopathological lesions, modulated oxidative stress and inflammation in serum and synovium, as well as reduced NLRP-3, RANKL, and caspase3 expression while boosting collagen-II expression in the ankle joints of arthritic and arthritic irradiated rats with comparable potency to MTX. Our findings suggest that EB, through its antioxidant and anti-inflammatory properties, has anti-arthritic and radioprotective properties in an arthritic irradiated model.

• Authors: Noura M Thabet, Mohamed K Abdel-Rafei, Mohamed M Amin
• Journal: Inflammopharmacology (Inflammopharmacology) Vol. 31 Issue 4 Pg. 1929-1949 (Aug 2023) ISSN: 1568-5608 [Electronic] Switzerland
• PMID: 37131046 (Publication Type: Journal Article)
• Copyright: © 2023. The Author(s).

Chemical References

• ebselen
• NLR Family, Pyrin Domain-Containing 3 Protein
• Antioxidants
• RANK Ligand
• Methotrexate
• Anti-Inflammatory Agents
• Collagen

Topics

• Rats
• Animals
• NLR Family, Pyrin Domain-Containing 3 Protein
• Antioxidants (pharmacology, therapeutic use)
• RANK Ligand (metabolism)
• Arthritis, Rheumatoid (metabolism)
• Arthritis, Experimental (drug therapy, pathology)
• Methotrexate (therapeutic use)
• Anti-Inflammatory Agents (pharmacology, therapeutic use)
• Collagen